C21 Investments Files 6-K, Submits Form 20-F

Ticker: CWLXF · Form: 6-K · Filed: May 8, 2024 · CIK: 831609

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, reporting

TL;DR

C21 Investments filed a 6-K, confirming they're using Form 20-F for reporting.

AI Summary

C21 Investments Inc. filed a Form 6-K on May 8, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its report under Form 20-F, which is typically used for annual reports by foreign issuers. The company's principal executive offices are located in Vancouver, BC.

Why It Matters

This filing signals C21 Investments Inc. is adhering to its reporting obligations as a foreign private issuer, providing transparency to investors regarding its regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to report information that the issuer makes public in its home country.

What is Form 20-F?

Form 20-F is the annual report required to be filed by foreign private issuers with the SEC, providing comprehensive information about the company's business, financial condition, and management.

When was C21 Investments Inc. previously known as Curlew Lake Resources Inc.?

The company was formerly known as Curlew Lake Resources Inc. with a date of name change on November 29, 2012, and prior to that, on April 9, 1988.

Where are C21 Investments Inc.'s principal executive offices located?

The principal executive offices of C21 Investments Inc. are located at Suite 1900-855 West Georgia St., Vancouver, BC, V6C 3H4.

What is the SIC code for C21 Investments Inc.?

The Standard Industrial Classification (SIC) code for C21 Investments Inc. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.

Filing Stats: 205 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-05-08 13:23:47

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. C21 Investments Inc. (Registrant) Date: May 8, 2024 By: /s/ Michael Kidd Michael Kidd Title: CFO

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing